GERPAC Congress 2026 highlights Dexmedetomidine diluted in 5% glucose and stored in polypropylene syringes is physicochemically stable for at least 21 days at 0.4 µg/mL and 28 days… read more.
GERPAC Congress 2026 highlights In-process quality control using augmented reality smart glasses (FlexOprep®) reduced risk levels and improved traceability in chemotherapy compounding, according to Loélya Istace (Pharmacy Department,… read more.
GERPAC Congress 2026 highlights Spironolactone gel tablets for paediatric patients can be reliably and reproducibly 3D printed in the hospital pharmacy at doses from 4 to 20 mg,… read more.
Older people could be monitored safely in their own homes without the need for intrusive cameras or wearable devices thanks to new research by Nottingham Trent University (NTU)…. read more.
Taking statins is linked to a lower risk of developing glaucoma and a reduced chance of it getting worse, suggest the findings of research published online in the… read more.
For-profit schools appear to be playing an outsized role in training the nation’s expanding nurse practitioner workforce, according to a study that found nearly one-third of newly licensed… read more.
What if checking medication levels were as simple as enjoying a lollipop? A candy-coated device, called Lollylab, could provide the answer. In ACS Sensors, researchers describe how the… read more.
GERPAC Congress 2026 highlights Automated compounding of 5-fluorouracil (5-FU) elastomeric infusion pumps cut preparation time and reduced the physical strain on pharmacy technicians, according to an ergonomic study… read more.
Roche announced that the FDA has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of stage… read more.
Three out of England’s seven NHS genetics laboratories are failing to routinely share vital information about genetic variants in public databases that helps patients with rare diseases access… read more.
Several reforms to EU chemicals policy and legislation have been introduced in recent years, with the aim of promoting the green transformation. Many of these reforms also affect… read more.
GERPAC Congress 2026 highlights Trastuzumab deruxtecan (Enhertu®) diluted in 5% glucose keeps its physicochemical, structural and functional characteristics for at least 28 days at 2–8°C when protected from… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
